Public Citizen's Access to Medicines Program and Afton Cissell, Counsel for U.S. Rep. Lloyd Doggett (D-TX) discuss a new approach to lower prescription drug prices in the U.S.
Medicare Part D is the largest purchaser of prescription medications in the world. But due to corporate lobbying pressure, the government cannot negotiate how much it pays for these medicines. With monopolies on prescriptions, corporations charge far too much for the medicines that keep families healthy.
The Medicare Negotiation and Competitive Licensing Act would allow direct negotiation with Big Pharma — and when prescription corporations don’t come to the table, the government could break their monopolies and allow less expensive medicines to be produced for Medicare.
Watch this video to hear about HR 6505 and how you can hold an in-district meeting to help this bill pass!